Angela CH, David HG. Neurofibromatosis type1:a multidisciplinary approach to care[J]. Lancet Neurol, 2014, 13(8):834-843.
[2]
Seminog OO, Goldacre MJ. Risk of benign tumours of nervous system,and of malignant neoplasms, in people with neurofibromatosis:population-based record-linkage study[J]. Br J Cancer, 2013, 108(1):193-198.
[3]
Walker L, Thompson D, Easton D, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK[J]. Br J Cancer, 2006, 95(2):233-238.
[4]
Jans SR, Schomerus E, Bygum A. Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia[J]. Pediatr Dermatol, 2015, 32(1):e29-e32.
[5]
Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma:a population-based UKCCSG study[J]. Br J Cancer, 1994, 70(5):969-972.
[6]
Bader JL, Miller RW. Neurofibromatosis and childhood leukemia[J]. J Pediatr,1978, 92(6):925-929.
